Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-24-014366

Chief Executive Officer gave up 9,479 shares (to pay taxes)

  • Chief Executive Officer acquired 14,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Chief Executive Officer 2024-07-31 Option exercise +14,000 $37.70 $527,800 49,421 D
Kelderman Kim Chief Executive Officer 2024-07-31 Shares withheld for taxes −9,479 $81.97 $776,994 39,942 D
Derivatives
Kelderman Kim Chief Executive Officer 2024-07-31 Option exercise · Stock Option (Right to Buy) −14,000 13,392 D
Loading xslF345X05/form4.xml…